Antisense compounds, compositions and methods are provided for modulating the expression of Syntaxin 4 interacting protein. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Syntaxin 4 interacting protein. Methods of using these compounds for modulation of Syntaxin 4 interacting protein expression and for treatment of diseases associated with expression of Syntaxin 4 interacting protein are provided.
Claims What is claimed is: 1. A compound up to 50 nucleobase's in length comprising at least a 14-nucleobase portion of SEQ ID NO: 19, 20, 21, 23, 24, 25, 28, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 47, 48, 49, 51, 52, 53, 54, 55, 56, 57, 58, 59, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 75, 76, 79, 88, 89, 91, 100, 101, 102, 103, 104, 105, 106, 107, 109, 110, 112, 113, 114, 116, 117, 120, 121, 122, 123, 124, 127, 128, 129, 130, 131, 133, 134, 136, 138, 139, 140, 141, 142, 143, 144, 146, 147, 150, 151, 152, 153, 154, 155, 157, 158, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 208, 213, 215, 216, 218, 221, 224, 227, 228, 229, 233, 236, 238, 239, 241, 243, 244, or 246 which inhibits the expression of human Syntaxin 4 interacting protein. 2. The compound of claim 1, which is an antisense oligonucleotide. 3. The compound of claim 2, wherein the antisense oligonucleotide comprises at least one modified internucleoside linkage. 4. The compound of claim 3, wherein the modified internucleoside linkage is a phosphorothioate linkage. 5. The compound of claim 2, wherein the antisense oligonucleotide comprises at least one modified sugar moiety. 6. The compound of claim 5, wherein the modified sugar moiety is a 2'-O-methoxyethyl sugar moiety. 7. The compound of claim 2, wherein the antisense oligonucleotide comprises at least one modified nucleobase. 8. The compound of claim 7, wherein the modified nucleobase is a 5-methylcytosine. 9. The compound of claim 2, wherein the antisense oligonucleotide is a chimeric oligonucleotide. 10. A method of inhibiting the expression of human Syntaxic 4 interacting protein in cells or tissues comprising contacting said cells or tissues in vitro with the compound of claim 1 so that expression of human Syntaxin 4 interacting protein is inhibited. 